Clinical Chemistry Link to Randox Laboratories Web Site
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Clinical Chemistry 30: 1457-1461, 1984;
This Article
Right arrow Full Text (PDF)
Right arrow Submit an electronic Letter to
the Editor about this paper
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Rattle, S. J.
Right arrow Articles by Forrest, G. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Rattle, S. J.
Right arrow Articles by Forrest, G. C.

Clinical Chemistry, Vol 30, 1457-1461, Copyright © 1984 by American Association for Clinical Chemistry

New separation method for monoclonal immunoradiometric assays and its application to assays for thyrotropin and human choriogonadotropin

SJ Rattle, DR Purnell, PI Williams, K Siddle and GC Forrest

We describe a novel separation procedure for immunoradiometric assays involving monoclonal antibodies in which both radiolabeled and capture antibodies are used in solution, the capture antibody being labeled with fluorescein isothiocyanate (FITC). Separation is achieved by incubation with anti-FITC antibodies on magnetic particles. This technique enhances reaction kinetics relative to those of assays in which a solid-phase capture antibody is used, thus allowing faster reaction times and more economic use of the monoclonal antibodies. The use of anti-FITC magnetic solid phase produces an assay having a highly specific separation method, minimal nonspecific binding, and high sensitivity. The method is illustrated by application to assays for thyrotropin and human choriogonadotropin.


The following articles in journals at HighWire Press have cited this article:


Home page
 J. Clin. Endocrinol. Metab.Home page
C. Flück, J. Deladoey, K. Rutishauser, A. Eblé, U. Marti, W. Wu, and P. E. Mullis
Phenotypic Variability in Familial Combined Pituitary Hormone Deficiency Caused by a PROP1 Gene Mutation Resulting in the Substitution of Arg->Cys at Codon 120 (R120C)
J. Clin. Endocrinol. Metab., October 1, 1998; 83(10): 3727 - 3734.
[Abstract] [Full Text]

Home page
 J PsychopharmacolHome page
A. J. Bond, S. Feizollah, and M. H. Lader
The effects of D-fenfluramine on mood and performance, and on neuroendocrine indicators of 5-HT function
J Psychopharmacol, January 1, 1995; 9(1): 1 - 8.
[Abstract] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1984 by the American Association for Clinical Chemistry.